Australian Clinical Labs Limited

ASX:ACL ISIN:AU0000148496

Australian Clinical Labs Limited (ASX:ACL) is a leading Australian private provider of pathology services. ACL is one of the largest private hospital pathology businesses nationally and in its established regions of Western Australia, Victoria, New South Wales, Queensland, South Australia and the Northern Territory, has an equivalent market position in community pathology to Sonic Healthcare and Healius. ACL also has a growing presence in the Australian Capital Territory.

 
 
    

查看其它語言版本

新聞

2011年9月28日亞洲活動報告:Fletcher Building (ASX:FBU)宣布昆士蘭煤層氣市場主要供氣合同

🕔9/28/2011 12:02:16 PM 8717

2011年9月28日亞洲活動報告:Fletcher Building (ASX:FBU)今天表示Iplex Pipelines已獲得一份1.2億澳元的合同;Integra Mining Limited (ASX:IGR)報告在Mt Monger地區實施地質普查鑽探獲得的空氣芯鑽探結果;African IronLimited (ASX:AKI)報告在其擁有92%權益的剛果共和國Mayoko鐵礦石項目的鑽探活動最新進展;Alchem​​ia Limited (ASX:ACL)今天表示其領先的癌症產品HA- Irinotecan的試驗結果大有希望;塔塔電信(BOM:500483)已成為為數不多的幾家向巴基斯坦提供全球IP/VPN服務的國際電信商之一。

閱讀全文
###

42,520 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 21) (過去30日: 133) (自發布以來: 7436) 

公司詳細

    總部
  • 1868-1892 Dandenong Road
    Clayton VIC 3168
    Australia
  • 電話
  • (03) 9538 6777 
  • 主要部門
  • 醫療-製藥 
  • 支柱產業
  • 保健 
  • 主頁
  • www.clinicallabs.com.au

更多新聞紀錄

  • 2024/11/01: Change in substantial shareholding from AEF*
  • 2024/10/31: Update - Notification of buy-back - ACL*
  • 2024/10/30: Becoming a substantial holder*
  • 2024/10/29: Becoming a substantial holder from MUFG*
  • 2024/10/29: Becoming a substantial holder from CBA*
  • 2024/10/29: Becoming a substantial holder*
  • 2024/10/29: Final Director's Interest Notice*
  • 2024/10/29: Final Director's Interest Notice*
  • 2024/10/29: Update - Notification of buy-back - ACL*
  • 2024/10/28: Becoming a substantial holder*
*refer to company website